Telix Pharmaceuticals | TLX - Interest Expense On Debt

Stock Price
9.69
Daily Change
-0.44 -4.30%
Monthly
-11.71%
Yearly
-66.75%
Q1 Forecast
10.34

Telix Pharmaceuticals reported AUD18.84M in Interest Expense on Debt for its fiscal semester ending in June of 2025.





Interest Expense On Debt Change Date
Cochlear AUD 2.65M 3.05M Jun/2025
CSL USD 104M 136M Jun/2025
Integral Diagnostics AUD 5.34M 6.08M Jun/2024
Mayne Pharma AUD 1.2M 50K Jun/2024
Medical Developments International AUD 18K 3K Jun/2025
Mesoblast USD 10.46M 260K Jun/2024
Neuren Pharmaceuticals AUD 0 0 Jun/2024
Paradigm Biopharmaceuticals AUD 1000 3K Jun/2025
Polynovo AUD 506K 130K Jun/2025
PYC Therapeutics AUD 17K 11K Jun/2025
Ramsay Health Care AUD 316.1M 10.4M Jun/2025
ResMed USD 775K 886K Dec/2024
Sonic Healthcare AUD 86.91M 43.94M Dec/2024